Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Srogoň, Jiří"'
Autor:
Srogoň, Jiří
Lenvatinib is a multi-targeted kinase inhibitor capable of inhibiting these kinases at nanomolar concentrations. For this reason, it is used as a drug in the treatment of various types of cancer. Like many other xenobiotics, lenvatinib is metabolized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2186::254b1814c4489b73a4de0bcce8d66773
http://www.nusl.cz/ntk/nusl-528513
http://www.nusl.cz/ntk/nusl-528513
